UTHR
United Therapeutics Corporation
NASDAQ: UTHR · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$571.07
+0.34% today
Updated 2026-04-29
Market cap
$25.03B
P/E ratio
20.48
P/S ratio
7.86x
EPS (TTM)
$27.89
Dividend yield
—
52W range
$272 – $608
Volume
0.6M
United Therapeutics Corporation (UTHR) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $49.39M | $48.95M | $-49.20M | $99.72M | $211.53M | $250.19M | $323.63M | $425.27M | $355.30M | $382.80M | $643.60M | $474.20M | $778.40M | $-206.60M | $755.70M | $598.20M | $802.50M | $978.00M | $1.33B | $1.56B |
| Capital expenditures | $15.63M | $38.66M | $124.42M | $95.40M | $18.64M | $35.98M | $111.91M | $31.91M | $47.44M | $49.79M | $43.20M | $86.30M | $184.40M | $83.70M | $59.30M | $120.80M | $138.80M | $230.40M | $246.50M | $520.50M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $-10.76M | $48.70M | $28.70M | $101.02M | $113.94M | $-15.71M | $30.11M | $320.79M | $190.10M | $280.30M | $12.10M | $73.50M | $-26.40M | $45.40M | $163.80M | $138.50M | $106.80M | $39.10M | $144.00M | $147.70M |
| Free cash flow | $33.75M | $10.29M | $-173.61M | $4.32M | $192.89M | $214.22M | $211.72M | $393.36M | $307.86M | $333.01M | $600.40M | $387.90M | $594.00M | $-290.30M | $696.40M | $477.40M | $663.70M | $747.60M | $1.08B | $1.04B |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | $29.60M | — | — | $0.00 | $0.00 | $0.00 | $26.61M | $190.17M | $39.31M | $7.70M | $0.00 | — | $14.00M | $38.50M | — | $94.30M | $98.00M | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | $151.81M | $-89.49M | $-8.65M | $124.86M | $113.44M | $434.10M | $191.20M | $-317.90M | $-35.90M | $69.20M | $300000.00 | $156.10M | $66.40M | — | — | — |